Address the increasing failure rate across drug discovery with next gen technologies such as deep learning, computational biology, big data and digital -- and identify winning drugs and therapies
Pharma organizations wanting to identify better drugs and personalized therapy find Wipro’s Integrated Next Gen Sequencing Platform a powerful way to overcome the challenges they face. The platform uses deep learning, computational biology, big data and digital technologies. It provides modeled pre-processing of DNA, in-memory database results, storage and real-time analysis of genomic data, advanced analytics, semantics, data search, visualization and reporting. These capabilities assist in a variety of ways, from rapid sequencing to identifying drug resistant genome in a specific condition, isolating cell-free DNA, provide preventive diagnosis, study high-risk patients and of course, develop better drugs and care therapy. One of the key advantages of using our Next Gen Sequencing Platform is that it brings down failure rates.
X
Contact Wipro
Please fill the required details to access the content
